KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Operating Margin (2019 - 2025)

Historic Operating Margin for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Q3 2025 value amounting to 40.49%.

  • Aurinia Pharmaceuticals' Operating Margin rose 231500.0% to 40.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.34%, marking a year-over-year increase of 411700.0%. This contributed to the annual value of 1.99% for FY2024, which is 502500.0% up from last year.
  • Aurinia Pharmaceuticals' Operating Margin amounted to 40.49% in Q3 2025, which was up 231500.0% from 28.69% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Operating Margin high stood at 40.49% for Q3 2025, and its period low was 5529.87% during Q1 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Operating Margin value was 38.97% (recorded in 2023), while the average stood at 382.87%.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Operating Margin soared by 1455704800bps in 2021, and later crashed by -128000bps in 2023.
  • Aurinia Pharmaceuticals' Operating Margin (Quarter) stood at 139.74% in 2021, then rose by 29bps to 98.82% in 2022, then skyrocketed by 33bps to 65.8% in 2023, then surged by 96bps to 2.79% in 2024, then surged by 1552bps to 40.49% in 2025.
  • Its last three reported values are 40.49% in Q3 2025, 28.69% for Q2 2025, and 34.97% during Q1 2025.